The FEI has announced an adverse analytical finding involving a prohibited substance.
The new case involves the use of Stanozolol, an anabolic steroid, which is a *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
Horse: Shiners Chic (FEI ID 103DF20/GBR)
Person Responsible: Jessica Sternberg (FEI ID 10055844/GBR)
Event: CRI3* – Katy, Texas (USA), 20-21.04.2017
Prohibited Substance: Stanozolol
The athlete has been provisionally suspended from the date of notification (5 July 2017) until the FEI Tribunal renders a decision. The horse has been provisionally suspended for two months.
Details on this case can be found here. Information on the substance is available on the searchable FEI Equine Prohibited Substances Database.
The FEI’s Prohibited Substances List is divided into two sections – Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) substances should never be found in the body of the horse.
In the case of an adverse analytical finding for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification. The horse is suspended for two months. In the case of a positive for a specified substance, provisional suspension is not automatic.
The FEI has also introduced the concept of Specified Substances. Specified Substances should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance.
FEI Media Contacts
Shannon Gibbons
Media Relations & Communications Manager
